Point-of-Care or Rapid Diagnostics
Market
Point-of-Care or Rapid Diagnostics Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Point-of-Care or Rapid Diagnostics Market Size and Growth
The Point-of-Care (POC) or Rapid Diagnostics market is experiencing significant growth, driven by increasing demand for timely clinical decision-making and home healthcare solutions. The global market size is projected to reach approximately $30 billion by 2027, fueled by advancements in technology and rising prevalence of chronic diseases. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Abbott
◍ Johnson & Johnson
◍ Siemens Healthcare
◍ Danaher
◍ Ascensia
◍ Bio-Rad Laboratories
◍ BioMerieux
◍ ARKRAY
◍ Nova Biomedical
◍ Trividia Health
◍ Quidel
◍ Accriva
◍ OraSure Technologies
◍ Helena Laboratories
◍ A. Menarini Diagnostics
◍ Abaxis (Zoetis)
The Point-of-Care Diagnostics market features key players like Roche, Abbott, and Siemens Healthcare, providing innovative, rapid testing solutions that enhance patient care. Companies invest in R&D, expand product portfolios, and improve accessibility, driving market growth. Notable sales figures include Abbott's $43 billion (2022) and Roche's $62 billion (2022).
◍ Ortho Clinical Diagnostics
Request Sample Report
Market Segmentation
By Application
Clinics
Hospitals ◍ Laboratory
Others
By Product
◍ Blood Glucose Testing
◍ Infectious Diseases Testing
◍ Cardiac Markers Testing
◍ Coagulation Testing
◍ Pregnancy and Fertility Testing
◍ Blood Gas/Electrolytes Testing ◍ Urinalysis Testing ◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
